Protein kinases have emerged as one of the most successful families of drug targets. To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes. Here we discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Development of a novel AAK1 inhibitor via Kinobeads-based screening
Scientific Reports Open Access 20 March 2024
-
Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist
Cell Death & Disease Open Access 24 August 2023
-
Prediction of kinase inhibitors binding modes with machine learning and reduced descriptor sets
Scientific Reports Open Access 12 January 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Knighton, D.R. et al. Science 253, 414–420 (1991).
Fedorov, O., Muller, S. & Knapp, S. Nat. Chem. Biol. 6, 166–169 (2010).
Knapp, S. & Sundstrom, M. Curr. Opin. Pharmacol. 17, 58–63 (2014).
Yang, J. et al. Chem. Biol. 18, 177–186 (2011).
Fabian, M.A. et al. Nat. Biotechnol. 23, 329–336 (2005).
Bantscheff, M. et al. Nat. Biotechnol. 25, 1035–1044 (2007).
Davis, M.I. et al. Nat. Biotechnol. 29, 1046–1051 (2011).
Zhao, Z. et al. ACS Chem. Biol. 9, 1230–1241 (2014).
Debreczeni, J.E. et al. Angew. Chem. Int. Edn. Engl. 45, 1580–1585 (2006).
Koeberle, S.C. et al. Nat. Chem. Biol. 8, 141–143 (2012).
Gammons, M.V. et al. Invest. Ophthalmol. Vis. Sci. 54, 6052–6062 (2013).
Liu, Q. et al. Chem. Biol. 20, 146–159 (2013).
Woyach, J.A. et al. N. Engl. J. Med. 370, 2286–2294 (2014).
Schindler, T. et al. Science 289, 1938–1942 (2000).
Pike, A.C. et al. EMBO J. 27, 704–714 (2008).
Hill, Z.B., Perera, B.G., Andrews, S.S. & Maly, D.J. ACS Chem. Biol. 7, 487–495 (2012).
Axten, J.M. et al. J. Med. Chem. 55, 7193–7207 (2012).
Wood, E.R. et al. Cancer Res. 64, 6652–6659 (2004).
Di Paolo, J.A. et al. Nat. Chem. Biol. 7, 41–50 (2011).
Guimarães, C.R. et al. J. Chem. Inf. Model. 51, 1199–1204 (2011).
Chaikuad, A. et al. Nat. Chem. Biol. 10, 853–860 (2014).
Zhang, J. et al. Nature 463, 501–506 (2010).
Hindie, V. et al. Nat. Chem. Biol. 5, 758–764 (2009).
Yap, T.A. et al. J. Clin. Oncol. 29, 4688–4695 (2011).
Ciceri, P. et al. Nat. Chem. Biol. 10, 305–312 (2014).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Müller, S., Chaikuad, A., Gray, N. et al. The ins and outs of selective kinase inhibitor development. Nat Chem Biol 11, 818–821 (2015). https://doi.org/10.1038/nchembio.1938
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1938
This article is cited by
-
Development of a novel AAK1 inhibitor via Kinobeads-based screening
Scientific Reports (2024)
-
Necroptosis inhibitors: mechanisms of action and therapeutic potential
Apoptosis (2024)
-
Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist
Cell Death & Disease (2023)
-
Improving the Prediction of Potential Kinase Inhibitors with Feature Learning on Multisource Knowledge
Interdisciplinary Sciences: Computational Life Sciences (2022)
-
Prediction of kinase inhibitors binding modes with machine learning and reduced descriptor sets
Scientific Reports (2021)
